Patent Assignment
Reel/Frame 035133/0328
Security Interest
Recorded: 2015-03-05
Pages: 10
Assignor
BANNER LIFE SCIENCES LLC
Executed: 2015-03-05
Assignee
UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
677 WASHINGTON BOULEVARD, 6TH FLOOR, STAMFORD, CONNECTICUT, 06901
Covered Properties
(57)
Enrobed Tablet
Patent:
6,482,516 →
Application:
08/391,486 →
Non-Gelatin Substitutes for Oral Delivery Capsules, Their Composition and Process of Manufacture
Patent:
6,214,376 →
Application:
09/140,758 →
Gum Acacia Substituted Soft Gelatin Capsules
Patent:
6,193,999 →
Application:
09/259,708 →
Chewable Soft Capsule
Patent:
6,258,380 →
Application:
09/262,660 →
Multiple Layer Softgel
Patent:
6,183,845 →
Application:
09/318,709 →
Ibuprofen-Containing Softgels
Patent:
6,251,426 →
Application:
09/389,003 →
Colored Gelatin-Based Formulations and Method
Patent:
6,685,961 →
Application:
09/695,537 →
Non-Gelatin Capsule Shell Formulation
Multiple Layer Softgel
Patent:
39,347 →
Application:
10/358,830 →
Chewable Soft Capsule
Enteric composition for the manufacture of soft capsule wall
Non-Gelatin Film and Method and Apparatus for Producing Same
Non-blooming gelatin and non-gelatin formulations
Application:
11/083,869 →
Publication:
US 2006/0088590
Enteric valproic acid
Application:
11/247,389 →
Publication:
US 2007/0082046
Controlled Release Preparation
Application:
11/275,563 →
Publication:
US 2006/0115527
Gastric reflux resistant dosage forms
Application:
11/316,830 →
Publication:
US 2007/0148248
Solvent system for enhancing the solubility of pharmaceutical agents
Application:
11/367,238 →
Publication:
US 2007/0053868
Enteric Valproic Acid
Application:
11/548,607 →
Publication:
US 2007/0098786
Lipophilic Vehicle-Based Dual Controlled Release Matrix System
Hydrophilic Vehicle-Based Dual Controlled Release Matrix System
Stable Solutions of Orlistat for Pharmaceutical Dosage Forms
Methods for Enhancing the Release and Absorption of Water Insoluble Active Agents
Gastric Reflux Resistant Dosage Forms
Progesterone Solutions for Increased Bioavailability
Chewable Soft Capsule
Chewable Soft Capsule
Chewable Soft Capsule
Enteric Soft Capsules
Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
Application:
13/862,199 →
Publication:
US 2013/0280323
Methods For Enhancing The Release And Absorption of Water Insoluble Active Agents
Gastric Reflux Resistant Dosage Forms
Enteric Soft Capsules
Chewable Soft Capsules
Controlled Release Preparations
Application:
14/460,747 →
Publication:
US 2015/0010623
Gastric Reflux Resistant Dosage Forms
Enteric Soft Capsules Comprising Polyunsaturated Fatty Acids
Non-blooming gelatin formulations
Application:
60/621,260 →
Solvent system for enhancing the solubility of pharmaceutical agents
Application:
60/659,679 →
Hydrophilic vehicle-based dual controlled release matrix system
Application:
60/730,406 →
Lipophilic vehicle-based dual controlled release matrix system
Application:
60/730,514 →
Stable Solutions of Orlistat for Pharmaceutical Dosage Forms
Application:
61/103,062 →
Methods for Enhancing the in Vitro Release and Absorption of Water Insoluble Active Agents
Application:
61/122,497 →
Progesterone Solutions for Increased Bioavailability
Application:
61/166,866 →
Soft Gelatin Capsules and Methods for Preparing the Same
Application:
61/893,721 →
Enteric High Purity Eicosapentaenoic Acid Pharmaceutical Composition and Method of Treating Hypertriglyceridemia
Application:
61/897,794 →
Enteric Soft Capsules of Controlled Release Dimethyl Fumurate
Application:
61/946,233 →
Controlled Release Enteric Soft Capsules of Dimethyl Fumarate
Application:
61/950,648 →
Abuse-Deterrent Controlled Release Formulations
Application:
61/976,237 →
Controlled Release Enteric Soft Capsules of Fumarate Esters
Application:
62/011,604 →
Liquid-Filled Immediate Release Soft Gelatin Capsules
Application:
62/014,714 →
Enteric Soft Capsule Compositions
Application:
62/015,063 →
All-Natural Enteric Soft Capsules Having Type-a Gelatin
Application:
62/015,818 →
Enteric Soft Capsules Comprising Active Ingredients
Application:
62/015,821 →
Enteric Soft Capsules Comprising Polyunsaturated Fatty Acids
Application:
62/017,489 →
Controlled Release Enteric Soft Capsules of Fumarate Esters
Application:
62/061,185 →
All-Natural Enteric Soft Capsules Having Type-a Gelatin
Application:
62/065,791 →
Abuse-Deterrent Controlled Release Formulations
Application:
62/101,431 →
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Dec 17, 2012
From: BANNER PHARMACAPS INC.
To: MORGAN STANLEY SENIOR FUNDING INC., AS COLLATERAL AGENT
Reel/Frame 029481/0962 →
Security Interest
Mar 11, 2014
From: BANNER PHARMACAPS INC.
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 032403/0790 →
Termination and Release of Security Interest in Patent Rights
Apr 23, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: BANNER PHARMACAPS INC.
Reel/Frame 032745/0454 →
Nunc Pro Tunc Assignment
Nov 19, 2014
From: BANNER PHARMACAPS INC
To: BANNER LIFE SCIENCES LLC
Reel/Frame 034294/0916 →
Change of Name
Dec 3, 2014
From: BANNER PHARMACAPS INC.
To: BANNER LIFE SCIENCES LLC
Reel/Frame 034359/0872 →
Release of Security Interest
Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC; BANNER PHARMACAPS INC.
Reel/Frame 036224/0623 →
Release of Security Interest
Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC
Reel/Frame 036239/0188 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded at Reel: 034359 Frame: 872. Assignor(S) Hereby Confirms the Assignment.
Nov 5, 2015
From: BANNER PHARMACAPS INC.
To: BANNER LIFE SCIENCES LLC
Reel/Frame 037055/0101 →
Security Interest (Term)
Dec 4, 2015
From: BIONPHARMA HEALTHCARE LLC (AS LICENSEE FROM BANNER LIFE SCIENCES, LLC)
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037212/0135 →
Security Interest (Revolver)
Dec 4, 2015
From: BIONPHARMA HEALTHCARE LLC (AS LICENSEE FROM BANNER LIFE SCIENCES, LLC)
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037211/0968 →
Assignment of Assignor's Interest
Dec 15, 2015
From: BANNER LIFE SCIENCES LLC
To: BIONPHARMA HEALTHCARE LLC
Reel/Frame 037297/0032 →
Security Interest (Term)
Dec 15, 2015
From: BIONPHARMA HEALTHCARE LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037292/0874 →
Security Interest (Revolver)
Dec 15, 2015
From: BIONPHARMA HEALTHCARE LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037292/0965 →
Security Interest
Jan 4, 2016
From: BIONPHARMA INC.; BIONPHARMA HEALTHCARE LLC
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP
Reel/Frame 037399/0659 →
Nunc Pro Tunc Assignment
Apr 8, 2016
From: BANNER PHARMACAPS INC.
To: BANNER LIFE SCIENCES LLC
Reel/Frame 038225/0022 →
Nunc Pro Tunc Assignment
Jun 29, 2017
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC
Reel/Frame 043032/0619 →
Notice of Succession of Agency for Patent Security Interest Previously Recorded at Reel/Frame (032403/0790)
Jul 12, 2017
From: UBS AG, STAMFORD BRANCH, AS PRIOR AGENT
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS SUCCESSOR AGENT
Reel/Frame 043173/0005 →
Release (Reel 032403 / Frame 0790)
Sep 28, 2017
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BANNER PHARMACAPS INC.
Reel/Frame 044038/0028 →
Assignment of Assignor's Interest
Jun 7, 2018
From: BIONPHARMA HEALTHCARE LLC
To: BIONPHARMA INC.
Reel/Frame 046016/0001 →
Release of Security Interest
Dec 8, 2020
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP
To: BIONPHARMA INC.; BIONPHARMA HEALTHCARE LLC
Reel/Frame 054575/0365 →